As world leaders gather at the UN for a High-Level Meeting on pandemics, a new AI-powered global infrastructure (the Pandemic Preparedness Engine and Global Pathogen Analysis Platform) is quietly being built to compress vaccine development from months to days.
Delphy reformulates Bayesian phylogenetics around explicit mutations and runs in a browser, cutting an H5N1 outbreak analysis from over 21 days to 42 minutes.
For the first time in an Ebola response, WHO and Flowminder are using anonymised mobile-phone data and modelling to predict where Congo's Bundibugyo outbreak will spread next. An early test called all ten hotspots. Here is what it means for pandemic preparedness.
Artificial intelligence is moving from the lab into the working machinery of pandemic preparedness, from spotting risky viruses in genetic data to scanning the world's news for early signals. Here is what it can and cannot do in 2026.
On 5 August 2026, the FDA approved Moderna's mFLUSIVA, the first mRNA seasonal flu vaccine. The decision is small in label and large in consequence, because the same platform that produced COVID-19 shots in months can now be redirected to a pandemic influenza strain in weeks.
